Giant Cell Arteritis - Ways to Precision Medicine
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWuerzburg University Hospital
About this trial
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Eligibility criteria
Qualifiers
Age greater or similar to 18 years
Primary diagnosis of GCA or PMR
Disqualifiers
Age under 18 years
lack of capacity to consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
400 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov